Home » Topics » Regulatory » EMA

EMA
RSS

European orphan drug designation recommended for VAL-083 for glioma

Jan. 8, 2013

EMA accepts MAA for aripiprazole depot formulation

Dec. 24, 2012

Intercell obtains positive CHMP opinion for pediatric use of its JE vaccine

Dec. 20, 2012

Roche's Perjeta receives CHMP recommendation for approval

Dec. 18, 2012

Alexza's MAA for Adasuve receives positive opinion from EMA advisory committee

Dec. 18, 2012

EMA committee recommends approval of Selincro for alcohol dependence

Dec. 17, 2012

Vanda's Fanaptum receives negative opinion from EMA

Dec. 17, 2012

EMA committee adopts negative opinion on MAA for Kynamro in HoFH

Dec. 17, 2012

The EMA validates PTC Therapeutics' MAA for ataluren

Dec. 10, 2012

FDA approves Cometriq, EMA accepts MAA

Nov. 30, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...